Abstract
It is a known fact that inflammation affects several physiological processes, including the functioning of the central nervous system. Additionally, impairment of lipid mechanisms/pathways have been associated with a number of neurodegenerative disorders and Alzheimer’s Disease (AD) is one of them. However, much attention has been given to the link between tau and beta- amyloid hypothesis in AD pathogenesis/prognosis. Increasing evidences suggest that biologically active lipid molecules could influence the pathophysiology of AD via a different mechanism of inflammation. This review intends to highlight the role of inflammatory responses in the context of AD with the emphasis on biochemical pathways of lipid metabolism enzyme, 5-lipoxygenase (5- LO).
Keywords: Alzheimer's Diseases, 5-lipoxygenase, Neuro Inflammation, Neurodegeneration, Lipid Molecule, Arachidonic Acid.
Current Neuropharmacology
Title:Inflammation Drives Alzheimer's Disease: Emphasis on 5-lipoxygenase Pathways
Volume: 19 Issue: 6
Author(s): Aisha Siddiqui, Sayeed Akhtar*, Zahoor Shah, Iekhsan Othman and Yatinesh Kumari*
Affiliation:
- Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha-21974,Saudi Arabia
- Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, 47500 Selangor,Malaysia
Keywords: Alzheimer's Diseases, 5-lipoxygenase, Neuro Inflammation, Neurodegeneration, Lipid Molecule, Arachidonic Acid.
Abstract: It is a known fact that inflammation affects several physiological processes, including the functioning of the central nervous system. Additionally, impairment of lipid mechanisms/pathways have been associated with a number of neurodegenerative disorders and Alzheimer’s Disease (AD) is one of them. However, much attention has been given to the link between tau and beta- amyloid hypothesis in AD pathogenesis/prognosis. Increasing evidences suggest that biologically active lipid molecules could influence the pathophysiology of AD via a different mechanism of inflammation. This review intends to highlight the role of inflammatory responses in the context of AD with the emphasis on biochemical pathways of lipid metabolism enzyme, 5-lipoxygenase (5- LO).
Export Options
About this article
Cite this article as:
Siddiqui Aisha , Akhtar Sayeed *, Shah Zahoor , Othman Iekhsan and Kumari Yatinesh *, Inflammation Drives Alzheimer's Disease: Emphasis on 5-lipoxygenase Pathways, Current Neuropharmacology 2021; 19 (6) . https://dx.doi.org/10.2174/1570159X18666200924122732
DOI https://dx.doi.org/10.2174/1570159X18666200924122732 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Phenolic Acids Exert Anticholinesterase and Cognition-Improving Effects
Current Alzheimer Research Human Adipose-Derived Stem Cells Delay Retinal Degeneration in Royal College of Surgeons Rats Through Anti-Apoptotic and VEGF-Mediated Neuroprotective Effects
Current Molecular Medicine The AMPAR Antagonist Perampanel Regulates Neuronal Necroptosis via Akt/GSK3β Signaling After Acute Traumatic Injury in Cortical Neurons
CNS & Neurological Disorders - Drug Targets Efficient Synthesis of 6-O-methyl-scutellarein from Scutellarin via Selective Methylation
Letters in Organic Chemistry Selection of Potential Pharmacological Targets in ALS Based on Whole- Genome Expression Profiling
Current Medicinal Chemistry Peptide Agonists and Antagonists with Potential Application in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Impact of COX-2 Inhibitors in Common Clinical Practice a Gastroenterologists Perspective
Current Topics in Medicinal Chemistry The Protein Therapy of Kallikrein in Cerebral Ischemic Reperfusion Injury
Current Medicinal Chemistry Drug-induced Cardiac Mitochondrial Toxicity and Protection: From Doxorubicin to Carvedilol
Current Pharmaceutical Design Meet the Editorial Board
Current Drug Targets Anti-Respiratory Syncytial Virus Mechanism of <i>Houttuynia cordata</i> Thunb Exploration based on Network Pharmacology
Combinatorial Chemistry & High Throughput Screening The Design of Competitive, Small-molecule Inhibitors of Coagulation Factor Xa
Current Topics in Medicinal Chemistry Ethyl Pyruvate: A Novel Treatment for Sepsis
Current Drug Targets A Revision of Polymeric Nanoparticles as a Strategy to Improve the Biological Activity of Melatonin
Current Medicinal Chemistry Mitochondriotropic Cationic Vesicles A Strategy Towards Mitochondrial Gene Therapy
Current Pharmaceutical Biotechnology Ozone: A Multifaceted Molecule with Unexpected Therapeutic Activity
Current Medicinal Chemistry Delivery of Therapeutic Proteins: Challenges and Strategies
Current Drug Targets Mechanisms of Vascular Hyporesponsiveness in Septic Shock
Current Vascular Pharmacology Mesenchymal Stromal Cell Therapy for Cardio Renal Disorders
Current Pharmaceutical Design Prospects for Caspase Inhibitors
Mini-Reviews in Medicinal Chemistry